Roche has more than five weight-loss companion medicines, CEO says
The the Swiss drugmaker will face off in the obesity area with leaders Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co.
Roche Diagnostics
-
Roche data shows simple blood test can help determine if someone has Alzheimer’s
Roche is developing the tests in partnership with Indianapolis-based Eli Lilly and Co. Earlier this year, the U.S. Food and Drug Administration granted a breakthrough device designation to the product.
Read More -
Roche Diagnostics names new North American chief
Brad Moore succeeds Matt Sause, who was appointed CEO of Roche Diagnostics globally in October.
Read More -
Chief of Roche Diagnostics North America leaving Indy for larger corporate job
Matt Sause, president and CEO of Roche Diagnostics North America since 2019, has been named CEO of Roche Diagnostics and a member of the corporate executive committee. He will relocate to the parent company’s offices in Basel, Switzerland.
Read More -
CORRECTED: Roche gets city’s OK to project messages on side of north-side HQ building
In a statement to IBJ, Roche said it hopes to display “supportive and inspiring messages” visible from I-69 as part of a new corporate initiative.
Read More
Articles
Lilly, Roche to get expedited FDA review for blood test to diagnose Alzheimer’s disease
Roche and Lilly said they believe the test could play an important role in improving access to early and accurate Alzheimer’s diagnosis.
BioCrossroads names Vince Wong as new CEO of Indy life sciences group
Wong’s appointment comes just a few weeks after BioCrossroads released a report warning that Indiana’s life-science sector is starting to lag the nation in growth and market share and will require a focused effort to stay competitive.
Roche to buy bowel drugmaker Telavant for $7.1 billion
Roche has come under pressure to improve its pipeline with medicines it can commercialize soon as a windfall of revenue from products used in the COVID-19 pandemic comes to an end.
Roche executive sues company for discrimination after losing job in restructuring
Brigitte Fernandes is suing Roche for sex discrimination and national origin discrimination. A Roche spokesman declined to comment, citing pending litigation.
Roche lands $340M to make rapid antigen tests in Indianapolis
The contract is part of the U.S. government’s effort to double its procurement of rapid COVID-19 tests to be delivered for free to Americans through a forthcoming federal website.
In a lockdown, Roche pushes ahead with new, different diagnostic tests
Matthew Sause took the helm of the 4,500-person Roche Diagnostics’ North American operations in Indianapolis in November 2019—just four months before the World Health Organization declared a pandemic and much of the planet went into lockdown.
Roche Diagnostics whistleblower wins $3.6M in settlement agreement
Crystal Derrick, who was a national account manager in Roche’s diabetes division, had accused the company of illegally paying insurance company Humana Inc. for access to certain formularies.
Roche’s COVID-19 antibody test gets emergency FDA approval
Roche Diagnostics’ North American headquarters in Indianapolis will be the shipping and distribution hub for all tests distributed in the United States, the company said.
Roche begins shipping emergency-approved COVID-19 tests across country
Indianapolis-based Roche Diagnostics said Monday that it has begun shipping an initial order of 400,000 COVID-19 test kits to a network of more than 30 hospital and laboratories.
Roche makes $4.8 billion acquisition bid for gene-therapy company
Spark Therapeutics Inc. will give Roche Holding a chance to make up ground in a field where single treatments may command more than $1 million. It also snaps up an asset that rivals like Novartis might have coveted.
City seeks walkability, better flow in Castleton
Castleton remains central Indiana’s most expansive retail corridor, but does its retail focus—and its car-centric layout—suggest trouble lies ahead?
Roche using data-driven diagnostic tools to reshape patient care
The company, which employs more than 3,000 on the northeast side, has been struggling on the diabetes side of its business. To bounce back, it is investing heavily in diagnostics, and is working to commercialize several products it hopes will be game-changers.
Roche, facing technician shortage, teams with UIndy to lure students
The “Roche Academy” will provide mentors, internships and special curriculum to biology and chemistry undergrads, along with financial incentives and a job offer after graduation.
Roche’s struggling diabetes unit looks toward ‘monster’ for boost
Roche Holding AG—the Basel, Switzerland-based parent of Indianapolis-based Roche Diagnostics—has enlisted a little green gremlin to help rescue its diabetes business after a decade of declining sales.
Roche hoping to gain edge with new diabetes-testing product
Roche Group is rolling out a new blood-glucose meter and a savings program for test strips, which it says it will make diabetes care more affordable.
Local Roche units sue pharmacies over alleged test-strip scheme
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
Roche Group to cut 157 workers, including dozens locally
The Swiss-based company confirmed Wednesday morning the cuts are part of a U.S. restructuring that will result in eliminating 133 full-time workers and 24 contractors.
Roche completes buildings as part of $300M overhaul
Since 2012, the company has built five buildings, refurbished existing buildings, made upgrades to IT infrastructure, and increased investments in its diabetes care manufacturing technology.
Obamacare’s medical device tax is (probably) killing jobs—but not a lot so far
A Census Bureau survey suggests that medical device firms created 20,000 fewer jobs from 2011 to 2013 than they should have—and some of those missing jobs probably can be blamed on Obamacare’s medical device tax.